Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study

Authors:

Abstract
No abstract available
Funding Information
  • Bayer
  • Amgen
  • Merck
  • Bristol-Myers Squibb
  • Roche
  • Sanofi
  • Celgene
  • Eli Lilly and Company
  • Servier

This publication has 30 references indexed in Scilit: